IQVIA Holdings Inc. (0JDM.L) LSE

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Ari Bousbib	Chief Executive Officer & Chairman	7.16M	1961
Eric Sherbet	Executive Vice President, General Counsel & Secretary	1.5M	1964
Alistair Grenfell	President of Commercial Solutions	1.7M	1974
W. Richard Staub	President of Research & Development Solutions	1.83M	1963
Michael J. Fedock	Executive Vice President & Chief Financial Officer	2.21M	1976
Keriann Cherofsky	Senior Vice President, Corporate Controller & Chief Accounting Officer	0	1985
Duane Sachs	Senior Vice President of Corporate Development	0	N/A
James G. Berkshire	Executive Vice President of Global Infrastructure & Operations	0	1974
Jeffrey A. Spaeder	Chief Medical & Scientific Officer	0	N/A
Kerri Joseph	Senior VP of Investor Relations & Treasurer	0	N/A

Name

Title

Pay

Year Born

Ari Bousbib

Chief Executive Officer & Chairman

7.16M

1961

Eric Sherbet

Executive Vice President, General Counsel & Secretary

1.5M

1964

Alistair Grenfell

President of Commercial Solutions

1.7M

1974

W. Richard Staub

President of Research & Development Solutions

1.83M

1963

Michael J. Fedock

Executive Vice President & Chief Financial Officer

2.21M

1976

Keriann Cherofsky

Senior Vice President, Corporate Controller & Chief Accounting Officer

1985

Duane Sachs

Senior Vice President of Corporate Development

N/A

James G. Berkshire

Executive Vice President of Global Infrastructure & Operations

1974

Jeffrey A. Spaeder

Chief Medical & Scientific Officer

N/A

Kerri Joseph

Senior VP of Investor Relations & Treasurer

N/A

Description

IQVIA Holdings Inc. is a global leader empowering the life sciences sector with advanced analytics, innovative technology solutions, and comprehensive clinical research services. Operating across the Americas, Europe, Africa, and the Asia-Pacific regions, its capabilities are organized into three main divisions. Within its Technology & Analytics Solutions segment, IQVIA delivers cloud-based applications alongside essential implementation services. It also specializes in real-world solutions, enabling clients to generate and disseminate crucial evidence that informs healthcare decisions and ultimately enhances patient outcomes. This segment extends its expertise to strategic and implementation consulting, encompassing advanced analytics and commercial process outsourcing. Furthermore, it furnishes comprehensive market performance data, tracking pharmaceutical sales, prescribing trends, treatment efficacy, and promotional activities at a granular level – from country-wide views down to regional, zip code, and individual prescriber insights, across diverse channels like retail, hospital, and mail order. The Research & Development Solutions segment offers a broad spectrum of support for clinical trials, from initial strategic planning and design to meticulous project management and clinical monitoring, including innovative virtual trial capabilities. Complementing these, it provides an extensive array of laboratory services, such as central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment focuses on engaging healthcare providers and patients, alongside offering scientific strategy and medical affairs support. IQVIA's client base spans pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. Additionally, the firm maintains a strategic alliance with HealthCore, Inc. Founded in 1982, the company was initially known as Quintiles IMS Holdings, Inc., before rebranding as IQVIA Holdings Inc. in November 2017. Its corporate headquarters are situated in Durham, North Carolina.